Chemical Compound
D-glycero-D-galacto-Non-2-enonic acid, 5-(acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy-; 5-(Acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid; (2R,3R,4S)-4-Guanidino-3-(prop-1-en-2-ylamino)-2-((1R,2R)-1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid; 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid; 4-Guanidino-Neu5Ac2en; 5-Acetamido-4-guanidino-2,3,4,5-tetradeoxy-D-glycero-D-galacto-non-2-enopyranosonic acid; GANA; GANA (inhibitor); GG 167; GR 121167X; Relenza; Zanamir; Zanamivir; Zanamiwei; Zanamvir
CAS Registry Number
139110-80-8
Primary record
D-glycero-D-galacto-Non-2-enonic acid, 5-(acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy-; 5-(Acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid; (2R,3R,4S)-4-Guanidino-3-(prop-1-en-2-ylamino)-2-((1R,2R)-1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid; 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid; 4-Guanidino-Neu5Ac2en; 5-Acetamido-4-guanidino-2,3,4,5-tetradeoxy-D-glycero-D-galacto-non-2-enopyranosonic acid; GANA; GANA (inhibitor); GG 167; GR 121167X; Relenza; Zanamir; Zanamivir; Zanamiwei; Zanamvir
- 库存
- 5,292 克
- 纯度
- 98.9 %
- CAS
- 139110-80-8
化合物标识与属性
- CAS
- 139110-80-8
- PubChem CID
- 60855
- SMILES
- CC(=O)N[C@@H]1[C@H](C=C(O[C@H]1[C@@H]([C@@H](CO)O)O)C(=O)O)N=C(N)N
- Canonical SMILES
- CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)OC(C(=O)O)=C[C@@H]1N=C(N)N
名称与同义词
- zanamivir
- Relenza
- Zanamivir hydrate
- GANA
- Zanamavir
- 139110-80-8
- 4-Guanidino-Neu5Ac2en
- Zanamir
- zanamivirum
- Zanamivi
- Dectova
- GANA (inhibitor)
- BAC-zanamivir
- Relenza (TN)
- GANA[inhibitor]
- 2qwe
- MODIFIED SIALIC ACID
- GG167
- Zanamivir (hydrate)
- 4-Guanidino-NeueAc2en
- Zanamivir (Relenza)
- Zanamivir (Standard)
- 4 Guanidino Neu5Ac2en
- GG-167
- ZANAMIVIRHYDRATE
- Zanamivir hydrate CRS
- ZANAMIVIR TFA
- Zanamivir (Relenza)?
- GR-121167X
- Relenza, GG 167
- 1a4g
- Zanamivir (USP/INN)
- RefChem:56369
- ZANAMIVIR [INN]
- DTXSID0023749
- ZANAMIVIR [MI]
- Zanamivir for assay CRS
- Zanamivir (USAN/INN)
- ZANAMIVIR [HSDB]
- ZANAMIVIR [USAN]
- Zanamivir hydrate [JAN]
- GlyTouCan:G87167MM
- L6O3XI777I
- UNII-L6O3XI777I
- ZANAMIVIR [VANDF]
- GR 121167X
- MFCD00866966
- Zanamivir [USAN:INN:BAN]
- D00NPP
- D01VUZ
- D04RPZ
- ZANAMIVIR [MART.]
- AC1L1U2A
- SCHEMBL9501
- SCHEMBL9502
- ZANAMIVIR [USP-RS]
- ZANAMIVIR [WHO-DD]
- CHEMBL222813
- DTXCID503749
- C12H20N4O7
- UNII-9E25RDB1Q0
- GG 167
- CHEBI:50663
- HSDB 7437
- Zanamivir [USAN:BAN:INN]
- BIDD:GT0349
- ARAIBEBZBOPLMB-UFGQHTETSA-N
- BDBM4934
- orb1305352
- ZANAMIVIR [ORANGE BOOK]
- Zanamivir, >=98% (HPLC)
- GTPL12307
- KS-00000XNB
- 139110-80-8 (free base)
- AOB3954
- GR-121167
- J05AH01
- ZANAMIVIR [USP MONOGRAPH]
- GR121167X
- CID60855
- G87167MM
- MSK10031
- ZINC3918138
- Tox21_112190
- BDBM50219992
- BDBM50330326
- CID:60855
- EBC-26618
- GS-167
- HY-13210R
- s3007
- AKOS015841013
- AKOS015994539
- C12-H20-N4-O7
- Tox21_112190_1
- ACN-038107
- BS-1017
- CCG-267828
- CS-0631
- DB00558
- MZ04270
- 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid
- NCGC00164561-01
- NCGC00164561-02
- NCGC00164561-08
- NCGC00164561-11
- BAC-zanamivir (influenza virus infection)
- HY-13210
- SC-20899
- SY102286
- SID:251963988
- J680.760G
- B2136
- CAS-139110-80-8
- FT-0657786
- NS00003906
- ST24050375
- Z0023
- (2R,3R,4S)-3-acetamido-4-(diaminomethylideneamino)-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid
- J1.917.534K
- 5-Acetamido-2,6-anhydro-3,4,5-trideoxy-4-guanidino-D-glycero-D-galacto-non-2-enonic acid
- A11613
- C08095
- C72554
- D00902
- D01937
- W-5155
- AB01566897_01
- BAC-zanamivir (influenza virus infection), TSRL
- ZMR
- 110Z808
- 2,4-Dideoxy-4-guanidino-2,3-didehydrosialic acid
- 4-guanidino-2,4-dideoxy-2,3-didehydro-N-acetylneuraminic acid
- A807485
- D053243
- EN300-26991905
- Q146075
- 4 Guanidino 2 Deoxy 2,3 Didehydro N Acetylneuraminic Acid
- 4-guanidino-2-deoxy-2,3-didehydro-N-acetylneuraminic acid
- Acid, 4-Guanidino-2-Deoxy-2,3-Didehydro-N-Acetylneuraminic
- BRD-K23067689-001-02-1
- 2,3-didehydro-2,4-dideoxy-4-guanidinyl-N-acetylneuraminic acid
- 5-(acetylamino)-2,6-anhydro-4-carbamimidamido-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid
- 551942-41-7
- 2,3-didehydro-2,4-dideoxy-4-guanidino-N-acetyl-D-neuraminic acid
- B0084-083764
- Zanamivir Working Standard (Secondary Reference Standard)
- (2R,3R,4S)-3-Acetamido-4-guanidino-2-((1R,2R)-1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid
- (2R,3R,4S)-3-acetamido-4-guanidino-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid
- GNA
- Zanamivir, United States Pharmacopeia (USP) Reference Standard
- 5-acetylamino-2,6-anhydro-4-guanidino-3,4,5-trideoxy-D-galacto-non-enoic acid
- 5-acetylamino-4-guanidino-6-(1,2,3-trihydroxypropyl)-5,6-dihydro-4H-pyran-2-carboxylic acid
- Zanamivir for assay, EuropePharmacopoeia (EP) Reference Standard
- (2R,3R,4S)-3-(acetylamino)-4-carbamimidamido-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid
- (2R,3R,4S)-3-acetamido-4-((diaminomethylene)amino)-2-((1R,2R)-1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid
- (2r,3r,4s)-4-[(diaminomethylidene)amino]-3-acetamido-2-[(1r,2r)-1,2,3-trihydroxypropyl]-3,4-dihydro-2h-pyran-6-carboxylic acid
- (2R,3R,4S)-4-carbamimidamido-3-acetamido-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid
- 2,3-Didehydro-2,4-dideoxy-4-guanidino-N-acetyl-alpha-neuraminic acid
- 4-Guanidino-2,3-didehydro-N-acetyl-2,4-dideoxy-alpha-neuraminic acid
- 5-(acetylamino)-4-{[amino(imino)methyl]amino}-2,6-anhydro-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid
- D-glycero-D-galacto-Non-2-enonic acid, 5-(acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy-
- N-Acetyl-2,4-dideoxy-4-guanidino-2,3-didehydro-alpha-neuraminic acid
- Bile acid carrier conjugated zanamivir (influenza virus infection, BAC technology), TSRL
- Zanamivir for system suitability, European Pharmacopoeia (EP) Reference Standard
- (+)-(4S,5R,6R)-5-Acetylamino-4-guanidino-6-((1R,2R)-1,2,3- trihydroxypropyl)-5,6-dihydro-4H-pyran-2-carboxylic acid hydrate
- (2R,3R,4S)-3-(ACETYLAMINO)-4-{[AMINO(IMINO)METHYL]AMINO}-2-[(1R,2R)-1,2,3-TRIHYDROXYPROPYL]-3,4-DIHYDRO-2H-PYRAN-6-CARBOXYLIC ACID
- (2R,3R,4S)-3-(acetylamino)-4-carbamimidamido-2-((1R,2R)-1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid
- (2R,3R,4S)-3-acetamido-4-(diaminomethylideneamino)-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acidEE
- (2R,3R,4S)-4-((diaminomethylidene)amino)-3-acetamido-2-((1R,2R)-1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid
- (2R,3R,4S)-4-Guanidino-3-(prop-1-en-2-ylamino)-2-((1R,2R)-1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid
- (4S)-4alpha-(Diaminomethyleneamino)-5beta-(acetylamino)-6alpha-[(1R,2R)-1,2,3-trihydroxypropyl]-5,6-dihydro-4H-pyran-2-carboxylic acid
- (4S)-6alpha-((1R,2R)-1,2,3-Trihydroxypropyl)-5beta-(acetylamino)-4alpha-guanidino-5,6-dihydro-4H-pyran-2-carboxylic acid hydrate
- (4S)-6alpha-[(1R,2R)-1,2,3-Trihydroxypropyl]-5beta-(acetylamino)-4alpha-guanidino-5,6-dihydro-4H-pyran-2-carboxylic acid
- (4S,5R,6R)-5-acetamido-4-(diaminomethyleneamino)-6-((1R,2R)-1,2,3-trihydroxypropyl)-5,6-dihydro-4H-pyran-2-carboxylic acid
- (4S,5R,6R)-5-acetylamino-4-guanidino-6-((1R,2R)-1,2,3-trihydroxy-propy)-5,6-dihydro-4H-pyran-2-carboxylic acid
- (4S,5R,6R)-5-acetylamino-4-guanidino-6-((1R,2R)-1,2,3-trihydroxy-propyl)-5,6-dihydro-4H-pyran-2-carboxylic acid
- (4S,5R,6R)-5-Acetylamino-4-guanidino-6-((1R,3R)-1,2,3-trihydroxy-propyl)-5,6-dihydro-4H-pyran-2-carboxylic acid
- (4S,5R,6R)-5-Acetylamino-4-guanidino-6-((R)-1,2,3-trihydroxy-propyl)-5,6-dihydro-4H-pyran-2-carboxylic acid
- (4S,5R,6R)-5-Acetylamino-4-guanidino-6-(1,2,3-trihydroxy-propyl)-5,6-dihydro-4H-pyran-2-carboxylic acid
- 139110-70-6
- 2-((1R,2R)-1,2,3-Trihydroxypropyl)-3alpha-acetylamino-4beta-guanidino-3beta,4alpha-dihydro-2alphaH-pyran-6-carboxylic acid
- 4-diaminomethylamino-3-methylcarboxamido-2-(1,2,3-trihydroxypropyl)-(3R)-3,4-dihydro-2H-6-pyrancarboxylic acid(Zanamivir)
- 5-(ACETYLAMINO)-4-((AMINOIMINOMETHYL)-AMINO)-2,6-ANHYDRO-3,4,5-TRIDEOXY-D-GLYCERO-D-GALACTO-NON-2-ENONIC ACID
- 5-(Acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic Acid
- 5-Acetamido-2,6-anhydro-4-(carbamimidoylamino)-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid
- 5-acetamido-2,6-anhydro-4-carbamimidamido-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid
- 5-Acetylamino-4-guanidino-6-(1,2,3-trihydroxy-propyl)-5,6-dihydro-4H-pyran-2-carboxylic acid
- 5-Acetylamino-4-guanidino-6-(1,2,3-trihydroxy-propyl)-5,6-dihydro-4H-pyran-2-carboxylic acid(zanamivir)
- 5-Formylamino-4-guanidino-6-(1,2,3-trihydroxy-propyl)-5,6-dihydro-4H-pyran-2-carboxylic acid
- 5beta-(Acetylamino)-4alpha-guanidino-6alpha-[(1R,2R)-1,2,3-trihydroxypropyl]-5,6-dihydro-4H-pyran-2-carboxylic acid
- D-GLYCERO-D-GALACTO-NON-2-ENONIC ACID, 5-(ACETYLAMINO)-4-((AMINOIMINOMETHYL)AMINO)-2,6-ANHYDRO-3,4,5-TRIDEOXY-
- D-Glycero-D-galacto-non-2-enonic acid, 5-(acetylamino)-4-((aminoiminomethyl)amino)-2,6-anhydro-3,4,5-trideoxy-, hydrate
- D-Glycero-D-galacto-non-2-enonic acid, 5-(acetylamino)-4-((aminoiminomethyl)amino)-2,6-anhydro-3,4,5-trideoxy-, hydrate (1:?)
- D-glycero-D-galacto-Non-2-enonic acid, 5-(acetylamino)-4-(aminoiminomethyl)amino)-2,6-anhydro-3,4,5-trideoxy-
- D-glycero-D-galacto-Non-2-enonic acid, 5-(acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy-; 5-(Acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid; (2R,3R,4S)-4-Guanidino-3-(prop-1-en-2-ylamino)-2-((1R,2R)-1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid; 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid; 4-Guanidino-Neu5Ac2en; 5-Acetamido-4-guanidino-2,3,4,5-tetradeoxy-D-glycero-D-galacto-non-2-enopyranosonic acid; GANA; GANA (inhibitor); GG 167; GR 121167X; Relenza; Zanamir; Zanamivir; Zanamiwei; Zanamvir
- ZNV